Keywords: BMI; body mass index; CI; confidence interval; CPC; cardiopulmonary complication; DLCO; diffusion capacity of carbon monoxide; FEV1; forced expiratory volume within 1 second; HRR; heart rate recovery; OR; odds ratio; ppoDLCO; predicted postoperative DLCO;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 10; 10.4; AE; acute exacerbation; CI; confidence interval; CT; computed tomography; DLCO; carbon monoxide diffusing capacity; FEV1; forced expiratory volume in 1 second; FVC; forced vital capacity; ILD; interstitial lung disease; IPF; idiopathic pulmonary
Keywords: BAE; bronchial artery embolization; DLCO; diffusing capacity for carbon monoxide; FEV1; forced expiratory volume in 1 second; FVC; forced vital capacity; PFT; pulmonary function test; PVA; polyvinyl alcohol;
Keywords: Dlco; diffusing capacity of the lung for carbon monoxide; HR; hazard ratio; HRCT; high-resolution CT; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; PFT; pulmonary function test; RR; relative risk; TLC; total lung capacity;
Keywords: 6MWT; 6-min walk test; ASCEND; Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis; CAD; coronary artery disease; CAPACITY; Clinical Studies Assessing Pirfenidone in Idiopathic Pulmonary Fibrosis: Research of Efficacy
Keywords: Pulmonary complications; HSCT; BMT; Allogeneic; Stem cell transplant; Lung shielding; Total body irradiation; Pulmonary function; DLCO; Adjusted DLCO; Long-term survivor
Keywords: 11.4; 36.1; 41.2; AUC; area under the receiver operating characteristic curve; CI; confidence interval; COPD; chronic obstructive pulmonary disease; DLCO; diffusion capacity of carbon monoxide; EI; emphysema index; FEV1; forced expiratory volume in 1 seco
Keywords: CHP; chronic hypersensitivity pneumonitis; Dlco; diffusing capacity of the lung for carbon monoxide; HRQL; health-related quality of life; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; MCS; mental component summary; PCS; physical com
Keywords: CTD-ILD; connective tissue disease-associated interstitial lung disease; Dlco; diffusion capacity of lung for carbon monoxide; HP; hypersensitivity pneumonitis; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; NSIP; nonspecific intersti
Keywords: Air pollution; Steel production; Epidemiology; Fine particulate air pollution; Metals; FEV1/FVC; Forced expiratory volume in 1-s/forced vital capacity; FEF50; Maximum mid-expiratory flow; TLC; Total lung capacity; FRC; Functional residual capacity; RV; Re
Keywords: Chronic obstructive pulmonary disease; Pulmonary to aortic artery diameter ratio; Pulmonary hypertension; Pulmonary artery diameter; COPD; chronic obstructive pulmonary disease; PA:A; pulmonary to aortic artery diameter ratio; PH; pulmonary hypertension;
Keywords: IPF; Idiopathic pulmonary fibrosis; JRS; Japanese Respiratory Society; SLB; surgical lung biopsy; VC; vital capacity; NHO-KCCMC; National Hospital Organization Kinki-Chuo Chest Medical Center; UIP; usual interstitial pneumonia; HRCT; high-resolution compu
Keywords: ANA; antinuclear antibody; CT; computed tomography; CTD; connective tissue disease; CTD-ILD; connective tissue disease-associated interstitial lung disease; DLCO; lung diffusing capacity for carbon monoxide; FVC; forced vital capacity; HRCT; high-resoluti
Keywords: ACPA; anticitrullinated protein antibody; CCP; cyclic citrullinated peptide; CTD; connective tissue disease; CXCL; CXC chemokine ligand; Dlco; diffusing capacity of lung for carbon monoxide; DMARD; disease-modifying antirheumatic drug; HRCT; high resoluti
Keywords: 6MWD; 6-min walk distance; BRASS; Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study; CCP; cyclic citrullinated peptide; Dlco; diffusion capacity of the lung for carbon monoxide; HRCT; high-resolution CT; ILA; interstitial lung abnormality
Keywords: 10.4; 41.2; 41.4; AE; acute exacerbation; ALI; acute lung injury; ARDS; acute respiratory distress syndrome; CI; confidence interval; CRP; C-reactive protein; CT; computed tomography; DLCO; diffusing capacity for carbon monoxide; FEV1; forced expiratory v
Keywords: 10; 28; DLCO; diffusing capacity of the lung for carbon monoxide; DLCO%; percentage of predicted DLCO; FEV1; forced expiratory volume in 1 second; FEV1%; percentage of predicted FEV1; ppo; predicted postoperative; VATS; video-assisted thoracoscopic surgic
Keywords: Dlco; diffusing capacity of the lung for carbon monoxide; HRCT; high-resolution CT; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; SSc; systemic sclerosis; SSc-ILD; systemic sclerosis-associated interstitial lung disease;
Keywords: 3D; Three dimensional; AM; Alveolar macrophage; APSGB; Academy of Pharmaceutical Science of Great Britain; BAL; Bronchoalveolar lavage; CAD; Cationic amphiphillic drugs; COPD; Chronic obstructive pulmonary disease; DLCO; Diffusing capacity of the lung for
Keywords: BPD; Bronchopulmonary dysplasia; CPET; Cardiopulmonary exercise testing; CLD; Chronic lung disease; DLCO; Lung diffusion capacity of carbon monoxide; FEV1; Forced expiratory volume in 1 second; MVV; Maximum voluntary ventilation; VËE; Minute ventilation;
Keywords: 10; 10.4; CI; confidence interval; CT; computed tomography; DLCO; diffusing capacity of carbon monoxide; %DLCO; percentage of predicted values for DLCO for age, gender, and height; FEV1; forced expiratory volume in 1 second; %FEV1; percentage of predicted
Keywords: Asthma; Misdiagnosis; Obesity; ACQ; Asthma Control Questionnaire; AQLQ; mini Asthma Quality of Life Questionnaire; BHR; bronchial hyperresponsiveness; BMI; body mass index; DLCO; diffusion capacity; ERV; expiratory reserve volume; ESS; Epworth Sleepiness
Keywords: COPD; DLCO; Smoke; Cardiac output; Workload
Keywords: DLCO; Pulmonary function; Quality control; Interpretation
The dutch national clinical audit for lung cancer: A tool to improve clinical practice? An analysis of unforeseen ipsilateral mediastinal lymph node involvement in the Dutch Lung Surgery Audit (DLSA)
Keywords: Staging non-small cell lung cancer; Unforeseen N2; Stage IIIA NSCLC; ASA; American Society of Anaesthesiologists; cN; clinical nodal stage; cT; clinical tumor stage; cTNM; clinical stage; DLCO; diffuse capacity of the lung for carbon monoxide; DLSA; Dutch
Physical activity in daily life in patients with idiopathic pulmonary fibrosis
Keywords: AEE; activity energy expenditure; BDI; Baseline Dyspnea Index; BMI; body mass index; COPD; chronic obstructive pulmonary disease; DLco; diffusing capacity of carbon monoxide; FEV1; forced expiratory flow in 1Â s; fIIP; fibrotic idiopathic interstitial pne
Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis
Keywords: SSc; systemic sclerosis; ILD; interstitial lung disease; MMF; mycophenolate mofetil; PM-DM; polymyositis and dermatomyositis; SLS; Scleroderma Lung Study; FVC; forced vital capacity; TLC; total lung capacity; DLCO; diffusing capacity of the lung for carbo
Severe idiopathic pulmonary fibrosis: A clinical approach
Keywords: IPF; idiopathic pulmonary fibrosis; UIP; Usual Interstitial Pneumonia; FVC; Forced Vital Capacity; SVC; Slow Vital Capacity; FEV1; Forced Expiratory Volume in the first second; TLC; Total Lung Capacity; RV; Residual Volume; DLCO; Diffusing Capacity of the
Office-Based Spirometry: A New Model of Care in Preoperative Assessment for Low-Risk Lung Resections
Keywords: ASA; American Society of Anesthesiologists; Dlco; diffusion capacity of the lungs for carbon monoxide; FEV1; forced expiratory volume in 1 second; FVC; forced vital capacity; LS; laboratory spirometry; OS; office spirometry; PFT; pulmonary function test;
Expresividad variable de una mutación fundadora en el gen EIF2AK4 en pacientes con enfermedad venooclusiva pulmonar hereditaria. Impacto en la supervivencia
Keywords: Enfermedad venooclusiva pulmonar familiar; Hipertensión arterial pulmonar; EIF2AK4; Vasodilatadores pulmonares; Etnia gitana; Hereditary pulmonary veno-occlusive disease; Pulmonary arterial hypertension; EIF2AK4; Pulmonary vasodilators; Romani ethnicity;
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD
Keywords: CANO; alveolar concentration of nitric oxide; COPD; chronic obstructive pulmonary disease; CV; closing volume; CC; closing capacity; DLCO; diffusion lung capacity for carbon monoxide; FENO; fraction of exhaled nitric oxide; FEV1; forced expiratory volume
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort
Keywords: cluster; interstitial lung disease; mortality; phenotype; pulmonary fibrosis; ANA; antinuclear antibody; ATS; American Thoracic Society; CHP; chronic hypersensitivity pneumonitis; CTD; connective tissue disease; CTD-ILD; connective tissue disease-associat
Acute bronchodilator therapy does not reduce wasted ventilation during exercise in COPD
Keywords: â©A; alveolar ventilation; â©A/Q; ventilation/perfusion; â©CO2; carbon dioxide production; â©D; dead space ventilation; â©E; minute ventilation; â©E/â©CO2; ventilatory equivalent for carbon dioxide; â©O2; oxygen uptake; COPD; chronic obstructive p
Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis
Keywords: lung function; lymphangioleiomyomatosis; lymphatic disease; sirolimus; VEGF-D; AML; angiomyolipoma; Dlco; diffusion capacity for carbon monoxide; LAM; lymphangioleiomyomatosis; MILES; Multicenter International Lymphangioleiomyomatosis Efficacy and Safety
Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features
Keywords: dermatomyositis; interstitial lung disease; MDA5; melanoma differentiation-associated gene 5; myositis; palmar papule; ulceration; CADM; clinically amyopathic dermatomyositis; CT; computed tomography; DLCO; diffusion capacity of the lung for carbon mono
WNT receptor signalling in lung physiology and pathology
Keywords: ABC; active β-catenin/non-phosphorylated β-catenin; APC; adenomatous polyposis coli; ATI; alveolar epithelial type I cell; ATII; alveolar epithelial type II cell; AXIN; axis inhibition protein; CBR2; carbonyl reductase 2; CK1; casein kinase 1; CELSR1; c
Hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis: A single-center experience
Keywords: IPF; idiopathic pulmonary fibrosis; AST; aspartate aminotransferase; ALT; alanine aminotransferase; CTCAE; Common Terminology Criteria for Adverse Events; ULN; upper limit of the normal range; BMI; body mass index; BSA; body surface area; FVC; forced vita
Short communicationDifferent histological subtypes of peripheral lung cancer based on emphysema distribution in patients with both airflow limitation and CT-determined emphysema
Keywords: ADC; adenocarcinoma; COPD; chronic obstructive pulmonary disease; CT; computed tomography; DLCO; diffusing capacity for carbon monoxide; FEV1; forced expiratory volume in 1Â s; FVC; forced vital capacity; LAA-950; low attenuation area belowâ950 hounsfie
Study of IPF among patients with gastro-esophageal reflux disease
Keywords: IPF; GERD; DLCO;
Air blood barrier phenotype correlates with alveolo-capillary O2 equilibration in hypobaric hypoxia
Keywords: High altitude pulmonary edema; DLCO; Diffusion subcomponents; Lung interstitial edema; Diffusion limitation; oxygen diffusion-transport;
Original Research: COPDClinical Features of Smokers With Radiological Emphysema But Without Airway Limitation
Keywords: clinical; emphysema; smokers; 6MWT; 6-min walk test; CAT; COPD assessment test; Dlco; diffusion capacity for carbon monoxide; SpO2%; percentage of oxygen saturation;
Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone
Keywords: Idiopathic pulmonary fibrosis; Pirfenidone; Biomarker; Surfactant protein D; Predictor; Prognosis; ALAT; Latin American Thoracic Association; ATS; American Thoracic Society; AUC; area under the curve; CI; confidence interval; DLCO; diffusion capacity for
Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome After Pneumonectomy
Keywords: ADC; adenocarcinoma; ANOVA; analysis of variance; ARDS; acute respiratory distress syndrome; ASA; American Society of Anesthesiologists; BMI; body mass index; COPD; chronic obstructive pulmonary disease; Dlco; diffusing capacity of the lung for carbon mon
The Roughton-Forster equation for DLCO and DLNO re-examined
Keywords: DLCO; DLNO; Roughton and Forster; Capillary volume;
Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease
Keywords: chronic lung disease; chronic obstructive pulmonary disease; clinical outcomes; Kansas City Cardiomyopathy Questionnaire; quality of life; transcatheter aortic valve replacement; CLD; chronic lung disease; DLCO; percent predicted diffusing capacity of
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER)
Keywords: bone marrow; idiopathic pulmonary fibrosis; mesenchymal stem cells; safety trial; 6-MWT; 6-min walk test; Dlco; diffusing capacity of the lungs for carbon monoxide; FDA; Food and Drug Administration; hMSCs; human mesenchymal stem cells; HRCT; high-reso
Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients
Keywords: COPD; chronic obstructive pulmonary disease; DH; dynamic hyperinflation; DLCO; diffusing capacity of the lung for carbon monoxide; EELV; end-expiratory lung volume; NFL; non-expiratory flow limitation during tidal breathing; EFL; expiratory flow limitatio
Decreased Serum Sirtuin-1 in COPD
Keywords: biomarker; COPD; emphysema; serum; sirtuin-1; 6MWD; 6-min walking distance; Aado2; alveolar-arterial oxygen difference; BODE; BMI, airflow obstruction, dyspnea, and exercise capacity; Dlco; diffusing capacity for carbon monoxide; DMEM; Dulbecco's Modified
Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosis
Keywords: Mac-2 binding protein (M2BP); Mac-2 binding protein glycosylation isomer (M2BPGi); Wisteria floribunda agglutinin positive-M2BP (WFA+-M2BP); Idiopathic pulmonary fibrosis (IPF); Biomarker; ALT; alanine aminotransferase; AST; aspartate aminotransferase; AU
Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
Keywords: chronic obstructive pulmonary disease; DLCO; lung cancer; screening; ATS; American Thoracic Society; AUC; area under the curve; BODE; Body Mass Index, Airflow Obstruction, Dyspnea, Exercise Performance database; DLCO; diffusing capacity for carbon monoxid